Europe debates incentives to combat antimicrobial resistance

In a blog post, the general counsel of European trade group EFPIA - the European Federation of Pharmaceutical Industries and Associations - has argued for effective incentives to be included in the EU general pharmaceutical legislation.

Approving the new rules earlier in the year, lawmakers aim to increase competitiveness in the industry and simplify the drug application process.

The law will also introduce a voucher system to encourage the development of new antibiotics.